EMEA-003328-PIP01-22

Products Management Services (PMS) - Implementation of International Organization for Standardization (ISO) standards for the identification of medicinal products (IDMP) in Europe - Chapter 1

EMEA-003232-PIP01-22-M01

Opinion/decision on a Paediatric investigation plan (PIP): Spikevax (previously COVID-19 Vaccine Moderna), elasomeran,imelsomeram,davesomeran, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Vaccines, PIP number: P/0373/2023

Opinion/decision on a Paediatric investigation plan (PIP): Comirnaty, Tozinameran,Tozinameran / famtozinameran, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Infectious diseases, PIP number: P/0393/2023

EMEA-002827-PIP01-20-M02

EMEA-002681-PIP01-19-M02

EMEA-002722-PIP01-19-M03

EMEA-002485-PIP01-18-M01

European Medicines Agency pre-authorisation procedural advice for users of the centralised procedure: document with tracked changes